Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Virginie Bertrand-Lehouillier"'
Autor:
Elodie M. Da Costa, Gregory Armaos, Gabrielle McInnes, Annie Beaudry, Gaël Moquin-Beaudry, Virginie Bertrand-Lehouillier, Maxime Caron, Chantal Richer, Pascal St-Onge, Jeffrey R. Johnson, Nevan Krogan, Yuka Sai, Michael Downey, Moutih Rafei, Meaghan Boileau, Kolja Eppert, Ema Flores-Díaz, André Haman, Trang Hoang, Daniel Sinnett, Christian Beauséjour, Serge McGraw, Noël J.-M. Raynal
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-14 (2019)
Abstract Background Cardiac glycosides are approved for the treatment of heart failure as Na+/K+ pump inhibitors. Their repurposing in oncology is currently investigated in preclinical and clinical studies. However, the identification of a specific c
Externí odkaz:
https://doaj.org/article/bdecc4d44be747e18ba1c9bfae4d8fcf
Publikováno v:
Biochemistry and Cell Biology. 96:117-130
Exposure to alcohol during in-utero development can permanently change the developmental programming of physiological responses, thereby increasing the risk of neurological illnesses during childhood and later adverse health outcomes associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69043620ffc693ce7c4f181b90f1113d
https://doi.org/10.1139/bcb-2017-0141
https://doi.org/10.1139/bcb-2017-0141
Autor:
André Haman, Noël J.-M. Raynal, Annie Beaudry, Moutih Rafei, Kolja Eppert, Yuka Sai, Serge McGraw, Elodie M. Da Costa, Jeffrey R. Johnson, Nevan J. Krogan, Trang Hoang, Chantal Richer, Daniel Sinnett, Meaghan Boileau, Ema Flores-Diaz, Pascal St-Onge, Christian Beauséjour, Maxime Caron, Gregory Armaos, Virginie Bertrand-Lehouillier, Gabrielle McInnes, Michael Downey, Gaël Moquin-Beaudry
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-14 (2019)
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-14 (2019)
Background Cardiac glycosides are approved for the treatment of heart failure as Na+/K+ pump inhibitors. Their repurposing in oncology is currently investigated in preclinical and clinical studies. However, the identification of a specific cancer typ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4535a644c781cb06c74ae89a12b626e0
http://europepmc.org/articles/PMC6563382
http://europepmc.org/articles/PMC6563382
Epigenetics has tremendously progressed since its beginnings and now has the potential to explain unsolved mechanisms of disease. In this introductory article, we provide an overview of terms and concepts associated with the most common epigenetic mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4565b0aee8ecd47070c044a741931d4a
https://doi.org/10.1016/b978-0-12-801238-3.65830-0
https://doi.org/10.1016/b978-0-12-801238-3.65830-0
Autor:
Gaël Moquin-Beaudry, Moutih Rafei, Trang Hoang, Jeffrey S. Johnson, Virginie Bertrand-Lehouillier, Gabrielle McInnes, Annie Beaudry, Nevan J. Krogan, Daniel Sinnett, André Haman, Elodie M. Da Costa, Yuka Sai, Pascal St-Onge, Michael Downey, Christian Beauséjour, Maxime Caron, Chantal Richer, Serge McGraw, Meaghan Boileau, Kolja Eppert, Gregory Armaos, Ema Flores-Diaz, Noël J.-M. Raynal
Targeting MYC oncogene remains a major therapeutic goal in cancer chemotherapy. Here, we demonstrate that proscillaridin, a cardiac glycoside approved for heart failure treatment exhibit anticancer selectivity towards high MYC expressing leukemic cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5263bbd3194d6fefb505d5786f889ad2
https://doi.org/10.1101/444133
https://doi.org/10.1101/444133
Autor:
Elodie Marie Da Costa, Gregory Armaos, Gabrielle McInnes, Annie Beaudry, Gael Moquin-Beaudry, Virginie Bertrand-Lehouillier, Maxime Caron, Pascal St-Onge, Jeffrey R. Jonhson, Nevan Krogan, Yuka Sai, Michale Downey, Moutih Rafei, Meaghan Boileau, Kolja Eppert, Ema Florez-Diaz, Andre Haman, Trang Hoang, Daniel Sinnett, Christian Beausejour, Serge McGraw, Noel J. Raynal
Publikováno v:
Cancer Research. 79:4332-4332
Targeting MYC oncogene remains a major therapeutic goal in anticancer therapies. Here, we demonstrate that proscillaridin, a cardiac glycoside approved for heart failure treatment, causing Na+/K+ pump inhibition, targets efficiently MYC overexpressin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba35d24bf4345381ca4d03d5daedc737
https://doi.org/10.1158/1538-7445.am2019-4332
https://doi.org/10.1158/1538-7445.am2019-4332